| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.41 | 7e-42 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.4 | 3e-38 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.37 | 6e-32 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-17 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.32 | 9e-14 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-07 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |